Silexion Therapeutics (SLXN): Navigating Challenges in the Quest for Cancer Solutions
Silexion Therapeutics Corp. (NASDAQ: SLXN) has recently made headlines with a significant uptick in its stock price, soaring +46.61% to $0.7700 during Tuesday’s premarket trading session. Despite this surge, the company faces a stark contrast in year-to-date (YTD) performance, with a staggering -95.16% decline in its stock compared to the S&P 500’s robust +20.81% YTD […]
